Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Sangaré MN, Baril JG, de Pokomandy A, Ferreira Guerra S, Carabali M, Laprise C, Thomas R, Klein M, Tremblay C, Roger M, Pexos C, Greenwald ZR, Machouf N, Durand M, Hardy I, Dakouo M, Trevisan A, Laporte L, Schnitzer ME, Trottier H. Sangaré MN, et al. Among authors: baril jg. Open Forum Infect Dis. 2020 Sep 4;7(11):ofaa404. doi: 10.1093/ofid/ofaa404. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33204746 Free PMC article.
High rates of forward transmission events after acute/early HIV-1 infection.
Brenner BG, Roger M, Routy JP, Moisi D, Ntemgwa M, Matte C, Baril JG, Thomas R, Rouleau D, Bruneau J, Leblanc R, Legault M, Tremblay C, Charest H, Wainberg MA; Quebec Primary HIV Infection Study Group. Brenner BG, et al. Among authors: baril jg. J Infect Dis. 2007 Apr 1;195(7):951-9. doi: 10.1086/512088. Epub 2007 Feb 16. J Infect Dis. 2007. PMID: 17330784
Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.
Côté P, Baril JG, Hébert MN, Klein M, Lalonde R, Poliquin M, Rouleau D, Therrien R, Vézina S, Willems B, Dion H, Junod P, Lapointe N, Lévesque D, Pinault L, Tremblay C, Trottier B, Trottier S, Tsoukas C, Piché A. Côté P, et al. Among authors: baril jg. Can J Infect Dis Med Microbiol. 2007 Sep;18(5):293-303. doi: 10.1155/2007/631054. Can J Infect Dis Med Microbiol. 2007. PMID: 18923731 Free PMC article.
Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitors.
Talbot A, Grant P, Taylor J, Baril JG, Liu TF, Charest H, Brenner B, Roger M, Shafer R, Cantin R, Zolopa A. Talbot A, et al. Among authors: baril jg. Antimicrob Agents Chemother. 2010 Jun;54(6):2473-9. doi: 10.1128/AAC.00096-10. Epub 2010 Apr 5. Antimicrob Agents Chemother. 2010. PMID: 20368406 Free PMC article.
Changes in function of HIV-specific T-cell responses with increasing time from infection.
Ndongala ML, Kamya P, Boulet S, Peretz Y, Rouleau D, Tremblay C, Leblanc R, Côté P, Baril JG, Thomas R, Vézina S, Boulassel MR, Routy JP, Sékaly RP, Bernard NF. Ndongala ML, et al. Among authors: baril jg. Viral Immunol. 2010 Apr;23(2):159-68. doi: 10.1089/vim.2009.0084. Viral Immunol. 2010. PMID: 20373996 Free PMC article.
116 results